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Reverse transcription is not solely a retroviral mechanism. Hepadnaviruses and caulimoviruses have RNA intermediates that are reverse transcribed 
into DNA. Moreover non-viral retroelements, retrotransposons, use reverse transcription in their transposition. All these retroelemenrs encode 
reverse transcriptase but each group developed their own expression modes capable of assuring a specific and efficient replication of their genomes. 
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1. INTRODUCTION 
The common mode of information transfer in 
biological systems is DNA to RNA to protein. Twenty 
years ago it was established that retroviruses used infor- 
mation transfer from RNA to DNA catalyzed by an en- 
zyme called reverse transcriptase [1,2]. Several years 
later it was found that reverse transcriptase was 
distributed in bacteria, yeast, insects, vertebrates and 
plants. An archiving role for reverse transcriptase has 
been suggested in the putative ancient transition from 
an RNA world to a DNA world. 
Other viruses, hepadna- and caulimoviruses, also use 
reverse transcriptase during the replication of their 
genomes. Based on this fact, these two virus families 
have been regrouped under the name of 
pararetroviruses. Retroviruses and pararetroviruses 
replicate from a genome-length RNA transcript which 
is the template for reverse transcription. This type of 
replication necessitates a strict recognition between the 
reverse transcriptase and the viral RNA. In fact, in the 
absence of a specific enzyme-template interaction, the 
reverse transcriptase could interact with the cellular 
RNAs causing, on the one hand, a deregulation in the 
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translation of the mRNA of the host cell and, on the 
other hand, a drop in the rate of replication of the viral 
genome. How does the reverse transcriptase recognize 
the viral RNA? Although similar in their modes of 
replication and even in their genomic organizations, the 
retro-, hepadna- and caulimoviruses have developed a 
reverse transcriptase-viral RNA recognition strategy 
which is particular to each group. 
2, IN RETROVIRUSES, REVERSE TRANSCRIPT- 
ASE IS GUIDED BY THE VIRAL CAPSID 
PROTEIN 
The retrovirus replication mechanism involves the 
synthesis of a terminally redundant genomic RNA that 
is packaged into a viral nucleocapsid and reverse 
transcribed into a DNA genome. However, the onset of 
reverse transcriptase is delayed until the mature virus 
re-enters a host cell. This explains why retroviruses con- 
tain an RNA genome. 
The retroviral reverse transcriptase is encoded by the 
ORF pal, located do~vnstream from the ORF gag, 
which codes for the virus capsid proteins. The expres- 
sion of pol necessitates the synthesis of a gag-pol 
polyprotein, later matured in capsid proteins, in pro- 
tease, in reverse transcriptase and in integrase. The 
maturation is catalyzed by an aspartic protease coded 
either by ORF gag for RSV [3], or by ORF pol for 
MoMLV [4] and HIV-I [5,6], or by a particular ORF, 
pro for HTLV-II [7], MPMV [8] and MMTV 191. 
Retroviruses use two strategies to generate a fusion pro- 
tein of gag-pol: either by read-through of a termination 
codon as in the case of the MoMLV [lo], or by 
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ribosomal frameshifting in the - 1 direction as for the 
RSV [I I] and HIV-l [ 121. The gag-pol polyprotein is 
produced about 5 percent as efficiently as the transla- 
tion product of gag alone [13]. The synthesis of such a 
fusion protein presents two advantages. Firstly, struc- 
tural proteins (gag) are synthesized in a greater quantity 
compared to enzymatic proteins (pal): for 5 molecules 
of reverse transcriptase, 100 molecules of capsid pro- 
teins are produced. Secondly, reverse transcriptase can 
be directed to viral capsids since gag codes for a zinc 
finger-like protein which binds the genomic RNA in the 
virion [ 141. For the foamy retroviruses, gag protein 
does not contain the cysteine motif of the nucleic acid- 
binding proteins; instead gag encodes a strongly basic 
protein vvhich likely binds the genomic RNA [15]. 
Thanks to the gag-pal fusion protein, reverse transcrip- 
tase is specifically attached to the viral RNA matrix and 
not to the RNAs of the host cell. Thus, in retroviruses, 
reverse transcriptase is strongly dependent on capsid 
proteins in translation as well as in replication. 
3. TEMPLATE-REVERSE TRANSCRIPTASE 
RECOGNITION IN RETROTRANSPOSONS, A 
MECHANISM SIMILAR TO THAT OF 
RETROVIRUSES 
Ty elements are a family of transposable elements 
which are dispersed throughout the yeast genome. They 
transpose by a retroviral-like mechanism within a virus- 
like particle synthesized from the product of the ORF 
TYA, analog of the retroviral ORF gag [16,17]. The 
ORF TYB, located downstream from the ORF TYA, 
encodes a polymerase which includes sequence 
homologies to retroviral reverse transcriptase, integrase 
and protease. TYB is synthesized in the form of a 
TYA:TYB fusion protein equivalent to the gag-pal pro- 
tein of retroviruses. For Tyl the expression of TYB is 
very efficient resulting in 2OO;o read-through into TYB 
from TYA [18], thanks to a ribosomal frameshifting in 
the + 1 direction [ 18,191. Due to these analogies with 
the retroviruses, the Ty elements have been regrouped 
in the retrotransposon family. 
Other retrotransposons have been characterized by 
the genome of various organisms such as insects, plants 
and mammals. All these elements transpose by reverse 
transcription and express their reverse transcriptase fus- 
ed to the capsid protein. The Drosophila transposable 
element copia [20,21], the Arubidopsis thaliuna 
retroelement Tal [22] and the Nicotiana tabacum 
retroelement Tnt 1 [23] possess in fact only a single ORF 
coding for a polyprotein having sequence homologies to 
retroviral zinc finger-like protein, reverse transcriptase, 
integrase and protease. Thus, as the retroviruses, 
retrotransposons synthesize their reverse transcriptase 
combined with a capsid protein in order to specifically 
direct the enzyme to the retroelement RNA. 
2 
4. IN HEPADNAVIRUSES, REVERSE TRANS- 
CRIPTASE IS EXPRESSED INDEPENDENTLY 
OF THE CAPSID PROTEIN 
Although they contain a DNA genome, hepad- 
naviruses resemble retroviruses in that they replicate via 
reverse transcription of an RNA pregenome. In the 
hepatitis B virus, or HBV, a typical member of the 
hepadnavirus group, reverse transcriptase is coded by 
the ORF P located downstream from the ORF C coding 
for the viral capsid. This genomic organization, com- 
mon to all hepadnav,iruses [23-261 is similar to that of 
the retroviruses and the retrotransposons. However, the 
analogies stop here as the hepadnaviruses have neither 
zinc finger-like protein, nor integrase nor aspartic pro- 
tease [27,28]. Moreover, it has been demonstrated that 
the synthesis and the encapsidation of hepadnavirus 
reverse transcriptase do not require formation of 
capsid-polymerase fusion proteins [29,30]. Follovving 
these studies, it cvas suggested that translation of the 
hepadnavirus reverse transcriptase was regulated by a 
cap-independent mechanism, the translation being in- 
itiated at the ATCi of ORF P [31]. A mechanism dif- 
ferent from that of the retroviruses takes place in the 
reverse transcriptase-RNA viral recognition of hepad- 
naviruses. 
The hepadnaviral gcnome contains a genome-linked 
protein attached to the 5’-end of its minus strand, sug- 
gesting that reverse transcription of the hepadnaviral 
RNA is primed by a protein and not by a tRNA 
molecule as is the case for the retroviruses. However, 
this primer protein corresponds to the N-terminal part 
of the polymerase encoded by the ORF P [32,33] and is 
therefore fused to the reverse transcriptase. Thanks to 
such a protein, the RNA of hepadnaviruses is recogniz- 
ed by its rev:erse transcriptase. This mechanism is possi- 
ble in hepadnaviruses as the capsid protein does not 
control the replication stage as strictly as in retroviruses 
although the reaction involving reverse transcription of 
hepadnaviral RNA is segregated from the cytosol 
within a subviral particle. In fact, the polymerase is not 
only required for reverse transcription but also for 
RNA packaging, the encapsidation function of the en- 
zyme being separated from its reverse transcriptase ac- 
tivity [34,35]. 
Unlike the retroviruses and the retrotransposons, the 
reverse transcriptase of the hepadnaviruses is expressed 
independently of the capsid protein due to the synthesis 
of a polymerase capable of interacting specifically with 
the viral RNA, of controlling the RNA packaging and 
of carrying out the reverse transcription stage. 
5. THE CAULIMOVIRUSES, A SPECIAL CASE 
AMONG THE RETROELEMENTS 
The most studied virus among the caulimoviruses is 
the CaMV [36]. The reverse transcriptase of CaMV is 
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coded by the ORF V located downstream from ORF IV 
coding for the major capsid protein. As with the 
retroviruses, the capsid protein possesses a zinc finger- 
like domain capable of interacting with the viral RNA 
[37]. Moreover, ORF V also codes for aspartic protease 
located in the N-terminal position of the reverse 
transcriptase [38], as in the MoMLV and the HIV-l. It 
thus seems possible that CaMV expresses its reverse 
transcriptase in the form of a precursor of the gag-pol 
type which is later matured by proteasic activity. 
However, an ORF IV-V fusion protein could not be 
detected in infected plants 139,403. Furthermore, 
translation experiments in vitro 141) or in a yeast system 
[42] did not make it possible to characterize such a fu- 
sion protein. Ultimately, thanks to different mutations 
located in the CaMV ORF IV/V overlapping region, 
Schultze et al. [43] showed that the reverse transcriptase 
is translated independently from the capsid ORF in 
much the same way as in the hepadnaviruses. 
retroviruses may represent retrotransposable elements 
which have acquired an envelope gene making it possi- 
ble for them to leave the cell. On the other hand, the 
origins of the hepadnaviruses and the caulimoviruses 
were more difficult to explain. The authors suggested 
that the pol gene was acquired by pre-existing viruses in 
the pararetroviruses. This fragment would also have in- 
cluded the protease domain in the case of the 
caulimoviruses. 
In such a hypothesis, it is understandable that 
pararetroviruses express their reverse transcriptase in- 
dependently of the capsid. In the absence of a fusion 
protein, the hepadnaviruses and the caulimo~~iruses 
would have developed their own expression modes 
capable of assuring a specific and efficient replication 
of their genomes: a primer protein for the hepad- 
naviruses and a cellular compartmentalization for the 
caulimoviruses due to their viroplasmic structures. 
The case of the caulimoviruses remains different 
nevertheless from the hepadnaviruses as the CaMV 
reverse transcription is not primed by a protein but by 
a tRNAme’. The CaMV thus developed a mechanism 
different from the hepadnaviruses to direct the reverse 
transcriptase toward the viral RNA. In fact, it has a 
particular ORF, ORF VI, coding for the major protein 
of the viroplasms. Characteristic of the caulimoviruses, 
viroplasms are cytoplasmic inclusions where the replica- 
tion and the encapsidation of viral genome are localiz- 
ed. Thus the reverse transcription of CaMV RNA is 
segregated from the cellular cytosol within the 
viroplasms. This compartmentalization would facilitate 
a specific recognition between the reverse transcriptase 
and its RNA template. 
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